Analystreport

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) was downgraded by analysts at Lifesci Capital from an "outperform" rating to a "market perform" rating.

Aeglea BioTherapeutics, Inc.  (AGLE) 
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aegleabio.com/investor-overview